Molecular Mechanism of YuPingFeng in the Treatment of Asthma Based on Network Pharmacology and Molecular Docking Technology

Figure 6

Molecular docking of active ingredients and core genes: (a) IL6-quercetin, (b) EGFR-quercetin, (c) CCND1-quercetin, (d) CASP3-kaempferol, (e) MAPK8-kaempferol, and (f) PPARG-kaempferol.

(a)

(b)

(c)

(d)

(e)

(f)